Literature DB >> 19199818

Context-dependent substrate recognition by protein farnesyltransferase.

James L Hougland1, Corissa L Lamphear, Sarah A Scott, Richard A Gibbs, Carol A Fierke.   

Abstract

Prenylation is a posttranslational modification whereby C-terminal lipidation leads to protein localization to membranes. A C-terminal "Ca(1)a(2)X" sequence has been proposed as the recognition motif for two prenylation enzymes, protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type I. To define the parameters involved in recognition of the a(2) residue, we performed structure-activity analysis which indicates that FTase discriminates between peptide substrates based on both the hydrophobicity and steric volume of the side chain at the a(2) position. For nonpolar side chains, the dependence of the reactivity on side chain volume at this position forms a pyramidal pattern with a maximal activity near the steric volume of valine. This discrimination occurs at a step in the kinetic mechanism that is at or before the farnesylation step. Furthermore, a(2) selectivity is also affected by the identity of the adjacent X residue, leading to context-dependent substrate recognition. Context-dependent a(2) selectivity suggests that FTase recognizes the sequence downstream of the conserved cysteine as a set of two or three cooperative, interconnected recognition elements as opposed to three independent amino acids. These findings expand the pool of proposed FTase substrates in cells. A better understanding of the molecular recognition of substrates performed by FTase will aid in both designing new FTase inhibitors as therapeutic agents and characterizing proteins involved in prenylation-dependent cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199818      PMCID: PMC2765569          DOI: 10.1021/bi801710g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

Review 1.  Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

Authors:  Michael H Gelb; Wesley C Van Voorhis; Frederick S Buckner; Kohei Yokoyama; Richard Eastman; Elisabeth P Carpenter; Chrysoula Panethymitaki; Katherine A Brown; Deborah F Smith
Journal:  Mol Biochem Parasitol       Date:  2003-02       Impact factor: 1.759

Review 2.  Serine protease mechanism and specificity.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

3.  Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state.

Authors:  C Huang; K E Hightower; C A Fierke
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

4.  Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice.

Authors:  Z Chen; J Sun; A Pradines; G Favre; J Adnane; S M Sebti
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

Review 5.  Enzymology and biology of CaaX protein prenylation.

Authors:  H W Fu; P J Casey
Journal:  Recent Prog Horm Res       Date:  1999

6.  The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.

Authors:  S B Long; P J Hancock; A M Kral; H W Hellinga; L S Beese
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

7.  Reaction path of protein farnesyltransferase at atomic resolution.

Authors:  Stephen B Long; Patrick J Casey; Lorena S Beese
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

8.  Conversion of Tyr361 beta to Leu in mammalian protein farnesyltransferase impairs product release but not substrate recognition.

Authors:  R A Spence; K E Hightower; K L Terry; L S Beese; C A Fierke; P J Casey
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

9.  Farnesylation of nonpeptidic thiol compounds by protein farnesyltransferase.

Authors:  K E Hightower; P J Casey; C A Fierke
Journal:  Biochemistry       Date:  2001-01-30       Impact factor: 3.162

10.  Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.

Authors:  Jerry M Troutman; Thangaiah Subramanian; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2007-09-14       Impact factor: 3.162

View more
  27 in total

1.  Finding a needle in the haystack: computational modeling of Mg2+ binding in the active site of protein farnesyltransferase.

Authors:  Yue Yang; Dhruva K Chakravorty; Kenneth M Merz
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  The function of two Rho family GTPases is determined by distinct patterns of cell surface localization.

Authors:  Hao Wu; Patrick Brennwald
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

3.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

Review 4.  Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions.

Authors:  Elaina A Zverina; Corissa L Lamphear; Elia N Wright; Carol A Fierke
Journal:  Curr Opin Chem Biol       Date:  2012-11-08       Impact factor: 8.822

5.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

6.  Insights into the mechanistic dichotomy of the protein farnesyltransferase peptide substrates CVIM and CVLS.

Authors:  Yue Yang; Bing Wang; Melek N Ucisik; Guanglei Cui; Carol A Fierke; Kenneth M Merz
Journal:  J Am Chem Soc       Date:  2012-01-06       Impact factor: 15.419

7.  Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates.

Authors:  Amanda J Krzysiak; Animesh V Aditya; James L Hougland; Carol A Fierke; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2009-11-12       Impact factor: 2.823

8.  Regioselective covalent immobilization of catalytically active glutathione S-transferase on glass slides.

Authors:  Rajesh Viswanathan; Guillermo R Labadie; C Dale Poulter
Journal:  Bioconjug Chem       Date:  2013-03-26       Impact factor: 4.774

9.  Spindly/CCDC99 is required for efficient chromosome congression and mitotic checkpoint regulation.

Authors:  Marin Barisic; Bénédicte Sohm; Petra Mikolcevic; Cornelia Wandke; Veronika Rauch; Thomas Ringer; Michael Hess; Günther Bonn; Stephan Geley
Journal:  Mol Biol Cell       Date:  2010-04-28       Impact factor: 4.138

10.  Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.

Authors:  Thangaiah Subramanian; June E Pais; Suxia Liu; Jerry M Troutman; Yuta Suzuki; Karunai Leela Subramanian; Carol A Fierke; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.